Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-03-18 12:59 pm Purchase | 2021-03-12 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC | SPHERA FUNDS MANAGEMENT LTD. | 33,788 6.290% | 33,788 (New Position) | Filing History |
| 2021-02-16 09:04 am Sale | 2020-12-31 | 13G | Orgenesis Inc. ORGS | SPHERA FUNDS MANAGEMENT LTD. | 52,522 2.130% | -59,787 (-53.23%) | Filing History |
| 2021-02-16 09:00 am Unchanged | 2020-12-31 | 13G | Sio Gene Therapies Inc. SIOX | SPHERA FUNDS MANAGEMENT LTD. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-02-16 08:57 am Unchanged | 2020-12-31 | 13G | Larimar Therapeutics, Inc. LRMR | SPHERA FUNDS MANAGEMENT LTD. | 0 0.000% | 0 (Unchanged) | Filing History |
| 2021-02-16 08:55 am Purchase | 2020-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR | SPHERA FUNDS MANAGEMENT LTD. | 250,000 1.510% | 250,000 (New Position) | Filing History |
| 2021-02-16 08:52 am Sale | 2020-12-31 | 13G | NEOS THERAPEUTICS INC NEOS | SPHERA FUNDS MANAGEMENT LTD. | 0 0.000% | -3,530,731 (Position Closed) | Filing History |
| 2021-02-16 06:09 am Sale | 2020-12-31 | 13G | Allot Ltd. ALLT | SPHERA FUNDS MANAGEMENT LTD. | 1,129,054 3.210% | -679,142 (-37.56%) | Filing History |